2015
DOI: 10.1093/bja/aeu410
|View full text |Cite
|
Sign up to set email alerts
|

Methylnaltrexone to prevent intrathecal morphine-induced pruritus after Caesarean delivery: a multicentre, randomized clinical trial

Abstract: Australian New Zealand Clinical Trials Registry (ACTRN12611000345987).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
6
0
3

Year Published

2016
2016
2023
2023

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 20 publications
(12 citation statements)
references
References 34 publications
3
6
0
3
Order By: Relevance
“…Prophylactic treatment with a peripheral mu antagonist was ineffective for the treatment of intrathecal morphine-induced pruritus, although a small clinical effect should not be excluded [16]. Similar results were found in an orthopedic surgery study.…”
Section: Opioid Receptor Antagonistssupporting
confidence: 80%
“…Prophylactic treatment with a peripheral mu antagonist was ineffective for the treatment of intrathecal morphine-induced pruritus, although a small clinical effect should not be excluded [16]. Similar results were found in an orthopedic surgery study.…”
Section: Opioid Receptor Antagonistssupporting
confidence: 80%
“…Prophylactic treatment with a peripheral mu antagonist was ineffective against the intrathecal morphine-induced pruritus in the peripartum period, although a small clinical effect could not be excluded [27]. In this regard, similar results were found in a study in orthopedic surgery.…”
Section: Prevention and Treatment Of Neuraxial Opioid Induced Pruritussupporting
confidence: 76%
“…At 24 h after surgery, each subject was reviewed by a blinded investigator. The overall incidence of pruritus was determined and whether treatment for the pruritus was required by the subject; maternal satisfaction of pain relief and control of pruritus was recorded (0–100, 0 = totally unsatisfied and 100 = totally satisfied); treatment for post-operative nausea and vomiting (PONV) as requested by the subject; the QoR score;[ 13 ] and the overall benefit of analgesia score (OBAS, range 0–28)[ 14 ] were recorded. Direct questioning was used to assess the presence of side effects, the ability to breastfeed, pass wind, open bowels and presence of a urinary catheter.…”
Section: Methodsmentioning
confidence: 99%